Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line pyla: Structure-activity relations and signal transduction mechanisms
Open Access
- 1 December 1994
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 9 (12) , 1935-1943
- https://doi.org/10.1002/jbmr.5650091213
Abstract
We previously showed that prostaglandin E2 (PGE2) can selectively inhibit collagen synthesis and gene transcription in the immortalized rat osteoblastic clonal cell line Py1a, particularly in the presence of insulin-like growth factor I (IGF-I). In the present study, we examined the structure-activity relations for this effect. PGF2α was approximately 100 times more potent than PGE2. The prostaglandin F receptor (FP) selective agonist, fluprostenol, was the most potent agonist tested, significantly inhibiting incorporation of [3H]proline into both collagen and noncollagen protein at 10−11 M, with more than 90% inhibition of collagen synthesis at 10−8 M. The PGE2 analog, sulprostone, and PGD2 showed activity similar to that of PGE2. PGI2 and its stable analog, carbacyclin, were the least effective. Parathyroid hormone (PTH), forskolin, and isobutylmethylxanthine (IBMX) were ineffective. Phorbol myristate acetate (PMA) inhibited collagen synthesis in a manner similar to that of the prostanoids. The inhibitory effects of PGF2α, fluprostenol, and PMA show a similar time course on α1 (I) procollagen mRNA levels. The inhibition appeared to be caused by a decrease in collagen gene transcription as measured by nuclear run-on analysis. Further evidence for a transcriptional effect was obtained with COLIA1 promoter-CAT reporter constructs, although these showed somewhat smaller effects of prostanoids on CAT activity than on mRNA levels or labeling. Based on these results, we conclude that in the Py1a cell line prostanoids inhibit collagen synthesis by a pathway involving activation of protein kinase C that is not dependent on adenylate cyclase. The structure-activity relations for this response suggest that it is mediated by an FP receptor and is distinctly different from the stimulatory effects on bone resorption and formation.Keywords
Funding Information
- USPHS (AR18063, AR38933)
This publication has 15 references indexed in Scilit:
- Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I.Endocrinology, 1993
- Prostaglandin F2 alpha-induced mitogenesis in MC3T3-E1 osteoblasts: role of protein kinase-C-mediated tyrosine phosphorylation.Endocrinology, 1993
- The existence of distinct classes of prostaglandin E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblastic clone MC3T3-E1Prostaglandins, Leukotrienes & Essential Fatty Acids, 1992
- Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells.The Journal of cell biology, 1992
- Prostaglandin E2Stimulates Insulin-Like Growth Factor I Synthesis in Osteoblast-Enriched Cultures from Fetal Rat Bone*Endocrinology, 1991
- The role of prostaglandins in bone in vivoProstaglandins, Leukotrienes & Essential Fatty Acids, 1990
- Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclastsJournal of Bone and Mineral Research, 1989
- Prostaglandin E1and F2αStimulate Differentiation and Proliferation, Respectively, of Clonal Osteoblastic MC3T3-E1 Cells by Different Second Messengersin Vitro*Endocrinology, 1987
- Comparing the Means of Several GroupsNew England Journal of Medicine, 1985
- Construction of DNA sequences complementary to rat .alpha.1 and .alpha.2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin DBiochemistry, 1984